- Home
- SMTI vs RCS Comparison
SMTI vs RCS Comparison
Compare SMTI & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMTI | RCS |
|---|---|---|
| Founded | 1982 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 290.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SMTI | RCS |
|---|---|---|
| Price | $24.40 | $6.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | 44.8K | ★ 141.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,877,532.00 | N/A |
| Revenue This Year | $21.60 | N/A |
| Revenue Next Year | $16.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | N/A |
| 52 Week Low | $18.90 | $4.51 |
| 52 Week High | $38.68 | $6.31 |
Technical Indicators
Market Signals| Indicator | SMTI | RCS |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 29.69 |
| Support Level | $24.00 | $6.00 |
| Resistance Level | $25.41 | $6.76 |
| Average True Range (ATR) | 1.15 | 0.17 |
| MACD | 0.35 | -0.04 |
| Stochastic Oscillator | 58.04 | 20.56 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.